SRPT - Sarepta Therapeutics - Stock Forecast

Healthcare - Sector
Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

SRPT is currently covered by 23 analysts with an average price target of $47.32. This is a potential upside of $24.19 (104.58%) from yesterday's end of day stock price of $23.13.

Sarepta Therapeutics's activity chart (see below) currently has 803 price targets and 675 ratings on display. The stock rating distribution of SRPT is 54.17% BUY, 17.71% SELL and 28.13% HOLD.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 56.23% with an average time for these price targets to be met of 268.13 days.

Highest price target for SRPT is $150, Lowest price target is $10, average price target is $35.2.

Most recent stock forecast was given by KOSTAS BILIOURIS from BMO on 22-Sep-2025. First documented stock forecast 20-Mar-2013.

Currently out of the existing stock ratings of SRPT, 52 are a BUY (54.17%), 17 are a SELL (17.71%), 27 are a HOLD (28.13%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Hold

$50

$27.36 (120.85%)

$50

17 days ago
(22-Sep-2025)

0/9 (0%)

$31.35 (168.10%)

Buy

$22

$-0.64 (-2.83%)

$98

24 days ago
(15-Sep-2025)

16/25 (64%)

$4.53 (25.93%)

229

Hold

$15

$-7.64 (-33.75%)

$160

1 months ago
(09-Sep-2025)

15/20 (75%)

$-2.64 (-14.97%)

133

Sell

$16

$-6.64 (-29.33%)

$10

1 months 18 days ago
(21-Aug-2025)

4/16 (25%)

$-4.06 (-20.24%)

246

Sell

$12

$-10.64 (-47.00%)

$9

1 months 24 days ago
(15-Aug-2025)

1/9 (11.11%)

$-9.81 (-44.98%)

27

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is SRPT (Sarepta Therapeutics) average time for price targets to be met?

On average it took 268.13 days on average for the stock forecasts to be realized with a an average price target met ratio 56.23

Which analyst has the current highest performing score on SRPT (Sarepta Therapeutics) with a proven track record?

DIFEI YANG

Which analyst has the most public recommendations on SRPT (Sarepta Therapeutics)?

Difei Yang has 22 price targets and 20 ratings on SRPT

Which analyst is the currently most bullish on SRPT (Sarepta Therapeutics)?

Christopher Marai with highest potential upside - $207.36

Which analyst is the currently most reserved on SRPT (Sarepta Therapeutics)?

Steve Brozak with lowest potential downside - -$79.57

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?